http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0103695-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcc79cd5393cd5f2812c89e1b869d09e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ebe1caa91dc3ae0d46c264bc4696c90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate | 2000-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dbb91e15ad41c41592289fa32d9c7df |
| publicationDate | 2001-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0103695-A1 |
| titleOfInvention | Improvement of bioavailability with vitamin c fatty acid esters |
| abstract | A method for increasing bioavailability of an orally administered pharmaceutical compound comprises orally coadministering the pharmaceutical compound to a mammal in need of treatment with the compound and a vitamin C fatty acid ester. Improved formulations of pharmaceutical compounds include a vitamin C fatty acid ester to enhance the bioavailability of the active ingredient of the pharmaceutical compound. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023152672-A1 |
| priorityDate | 1999-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 227.